Intuitive Surgical, Inc. $ISRG Shares Purchased by Wormser Freres Gestion

Wormser Freres Gestion grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.4% in the second quarter, according to its most recent filing with the SEC. The fund owned 2,316 shares of the medical equipment provider’s stock after acquiring an additional 180 shares during the period. Intuitive Surgical comprises about 0.7% of Wormser Freres Gestion’s portfolio, making the stock its 22nd largest holding. Wormser Freres Gestion’s holdings in Intuitive Surgical were worth $1,258,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Brighton Jones LLC boosted its position in shares of Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares during the period. NBC Securities Inc. purchased a new stake in Intuitive Surgical during the first quarter valued at about $135,000. Vest Financial LLC boosted its holdings in shares of Intuitive Surgical by 73.5% in the first quarter. Vest Financial LLC now owns 4,728 shares of the medical equipment provider’s stock worth $2,342,000 after buying an additional 2,003 shares during the period. Pines Wealth Management LLC purchased a new position in shares of Intuitive Surgical in the first quarter worth approximately $216,000. Finally, Sivia Capital Partners LLC raised its holdings in shares of Intuitive Surgical by 7.5% during the first quarter. Sivia Capital Partners LLC now owns 894 shares of the medical equipment provider’s stock valued at $443,000 after acquiring an additional 62 shares during the period. 83.64% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, Director Amy L. Ladd sold 336 shares of the firm’s stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the sale, the director owned 1,074 shares in the company, valued at approximately $504,898.14. This trade represents a 23.83% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the company’s stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares of the company’s stock, valued at approximately $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock valued at $21,716,492 in the last three months. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Up 2.1%

NASDAQ:ISRG opened at $452.35 on Monday. The firm has a market capitalization of $162.16 billion, a PE ratio of 63.09, a PEG ratio of 4.74 and a beta of 1.61. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The firm’s fifty day simple moving average is $463.55 and its 200 day simple moving average is $500.11.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business’s quarterly revenue was up 21.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.78 earnings per share. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on ISRG shares. Royal Bank Of Canada restated an “outperform” rating and issued a $615.00 price target on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. Evercore ISI lifted their price target on Intuitive Surgical from $470.00 to $550.00 and gave the company an “in-line” rating in a report on Tuesday, July 8th. Wells Fargo & Company upped their price target on Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research report on Wednesday, July 23rd. Finally, UBS Group increased their price objective on Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 23rd. Fourteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $594.19.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.